In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.

Let?s look at the sky and we?ll find an invention So how is it with the inventions? [Article on IP-Blog.pl]

Author: Olimpia Misztal, assistant in Patent Department On the 14th April, every year, in the calendar Czytaj dalej

Patpol’s patent attorneys in the WIPR Leaders Directory 2022 guide!

We are very pleased to announce that Izabella Dudek-Urbanowicz, Aleksandra Kryśka and Joanna Piłka have Czytaj dalej

Patpol and its patent and trademark attorneys recommended in the latest IP Stars 2020 rankings

In the latest IP Stars 2020 ranking recognizing the best IP law firms in terms Czytaj dalej